Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0000950170-24-108533 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-09-20 | 2024-09-18+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.19 | -16.3K | 1.50M | -1% | -$394.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-20 | S | D | 7,109 | $24.19 | 1,489,620 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8963. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-09-19 | S | D | 27 | $25.10 | 1,496,729 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-19 | S | D | 5,671 | $24.30 | 1,496,756 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $24.00 to $24.9749. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2024-09-18 | S | D | 3,500 | $24.00 | 1,502,427 | D | — | — |